Francesco Grossi

17PUBLICATIONS
148CO-AUTHORS
Memory and attentionPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 10, 2026
Reply to: "Beyond Response Rates: Interpreting Long-Term Benefit in CheckMate 743" and "Beyond Statistical Significance: Methodological Fragility and Censoring Bias in the 5-Year Update of CheckMate 743".

|Feb 24, 2026
Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743.

Arnaud Scherpereel, Paul Baas, Anna K Nowak

|May 07, 2025
Effect of immuno-oncology on clinical and economic outcomes for a selection of cancers in Italy.

Beatrice Canali, Giovanni Apolone, Paolo A Ascierto

|Nov 09, 2023
Implementation of Precision Oncology in the National Healthcare System: A Statement Proposal Endorsed by Italian Scientific Societies.

Gianpiero Fasola, Maria C Barducci, Valeria D Tozzi

|May 01, 2023
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.

Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary

|Apr 12, 2023
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.

Luca Cantini, Francesco Paoloni, Federica Pecci

Pageof 3

Frequent Collaborators

6 joint publications

Alice Indini

4 joint publications

Alessio Cortellini

4 joint publications

Michele Ghidini

3 joint publications

Aldo Bonaventura